Archive: 19/08/2014
AstraZeneca says DOJ closes probe into drug trial
British drugmaker AstraZeneca says the U.S. Department of Justice has closed its investigation into a clinical trial of the company's blood thinner Brilinta, and plans no further action.
Aug 19, 2014
Suspected cases in Austria not Ebola: ministry (Update)
Austria's health ministry gave the all-clear Tuesday evening after regional authorities earlier reported two suspected cases of Ebola in two men recently returned from Nigeria.
Aug 19, 2014
Denmark links new listeria death to tainted meat
Danish health officials say a listeria outbreak caused by contaminated meat may have killed an 11th person.
Aug 19, 2014
Perampanel for epilepsy: Still no proof of added benefit
The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive ("add-on") therapy for adults and children aged 12 years and older with epileptic fits (seizures). In a new early benefit assessment ...
Aug 19, 2014
Ruxolitinib for myelofibrosis: Indication of considerable added benefit
Ruxolitinib (trade name: Jakavi) has been approved since August 2012 for the treatment of adults with myelofibrosis. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), ...
Aug 19, 2014